You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

dabrafenib

Showing 1 - 25 of 78
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Cancer Trial (Dabrafenib, Trametinib)

Not yet recruiting
  • Cancer
  • (no location specified)
May 25, 2023

BRAF NP_004324.2:p.V600E, BRAF V600K Mutation Present, Thyroid Gland Anaplastic Carcinoma Trial in Duarte, Columbus (Dabrafenib,

Recruiting
  • BRAF NP_004324.2:p.V600E
  • +2 more
  • Dabrafenib
  • +2 more
  • Duarte, California
  • +1 more
Jan 19, 2023

Metastatic Melanoma, BRAF Gene Mutation Trial in Lexington (Nilotinib 100mg, Nilotinib 200mg, Nilotinib 300mg)

Recruiting
  • Metastatic Melanoma
  • BRAF Gene Mutation
  • Nilotinib 100mg
  • +5 more
  • Lexington, Kentucky
    Markey Cancer Center
Jul 22, 2022

Clinical Stage IV Cutaneous Melanoma AJCC v8, Metastatic Malignant Tumor in the Brain, Metastatic Malignant Tumor in the CNS

Recruiting
  • Clinical Stage IV Cutaneous Melanoma AJCC v8
  • +3 more
  • Dabrafenib
  • MEK-1/MEKK-1 Inhibitor E6201
  • Scottsdale, Arizona
  • +2 more
Jan 4, 2023

Metastatic Colorectal Cancer Trial in Boston (Dabrafenib, Trametinib, PDR001)

Recruiting
  • Metastatic Colorectal Cancer
  • Dabrafenib
  • +2 more
  • Boston, Massachusetts
  • +1 more
Jun 24, 2022

Pathologic Stage IIIB Cutaneous Melanoma AJCC v8, Pathologic Stage IIIC Cutaneous Melanoma AJCC v8, Pathologic Stage IIID

Active, not recruiting
  • Pathologic Stage IIIB Cutaneous Melanoma AJCC v8
  • +2 more
  • Dabrafenib
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Aug 9, 2022

Thyroid Gland Anaplastic Carcinoma, Thyroid Gland Squamous Cell Carcinoma Trial in Houston, Salt Lake City (procedure, drug,

Recruiting
  • Thyroid Gland Anaplastic Carcinoma
  • Thyroid Gland Squamous Cell Carcinoma
  • Conventional Surgery
  • +5 more
  • Stanford, California
  • +5 more
Jan 26, 2023

Melanoma, Adjuvant Trial (Dabrafenib and Trametinib, Dabrafenib, Trametinib)

Available
  • Melanoma
  • Adjuvant
  • Dabrafenib and Trametinib
  • +2 more
  • (no location specified)
Mar 1, 2022

Metastatic Malignant Tumor in the Brain, Metastatic Melanoma, Stage III Cutaneous Melanoma AJCC v7 Trial in Houston (drug,

Active, not recruiting
  • Metastatic Malignant Neoplasm in the Brain
  • +7 more
  • Houston, Texas
    M D Anderson Cancer Center
Jun 15, 2022

Melanoma Trial in Sydney, Wollstonecraft, Melbourne (Dabrafenib, Trametinib, Pembrolizumab)

Active, not recruiting
  • Melanoma
  • Dabrafenib
  • +2 more
  • Sydney, New South Wales, Australia
  • +2 more
Apr 4, 2022

BRAF V600E Mutation Present, BRAF V600K Mutation Present, Metastatic Malignant Solid Tumor Trial in Boston (Dabrafenib,

Active, not recruiting
  • BRAF V600E Mutation Present
  • +9 more
  • Dabrafenib
  • +4 more
  • Boston, Massachusetts
  • +1 more
Jun 28, 2022

Anaplastic Thyroid Cancer, Thyroid Cancer, BRAF Gene Mutation Trial in United States (Dabrafenib, Trametinib)

Recruiting
  • Anaplastic Thyroid Cancer
  • +3 more
  • Basking Ridge, New Jersey
  • +6 more
Jul 1, 2022

Dabrafenib in Combination With Trametinib as Adjuvant Treatment

Recruiting
  • Melanoma
  • Zhengzhou, Henan, China
  • +6 more
Mar 17, 2022

NSCLC Trial in China (Dabrafenib, Trametinib)

Recruiting
  • Carcinoma, Non-Small-Cell Lung
  • Harbin, Heilongjiang, China
  • +9 more
Jun 13, 2022

Melanoma Trial in Boston (MCS110, Dabrafenib, Trametinib)

Active, not recruiting
  • Melanoma
  • Boston, Massachusetts
    Dana Farber Cancer Institute
Dec 14, 2022

Patients With Completely Resected High-risk Stage III Melanoma.

Recruiting
  • Melanoma
  • Bursa, Gorukle, Turkey
  • +9 more
Feb 28, 2022

Melanoma Trial in Boston (Trametinib, Dabrafenib, INCB039110)

Active, not recruiting
  • Melanoma
  • Boston, Massachusetts
    Massachusetts General Hospital
Nov 1, 2021

Melanoma Trial in Louisville (Dabrafenib, Trametinib, Metformin)

Recruiting
  • Melanoma
  • Dabrafenib
  • +2 more
  • Louisville, Kentucky
  • +1 more
Oct 22, 2021

Cancer, Melanoma Trial in Worldwide (Dabrafenib, Trametinib)

Completed
Has Results
  • Cancer
  • Melanoma
  • Guangzhou, Guangdong, China
  • +12 more
Jan 4, 2022

Low Grade Glioma (LGG) of Brain With BRAF Aberration, High Grade Glioma (HGG) of the Brain With BRAF Aberration, Low Grade

Recruiting
  • Low Grade Glioma (LGG) of Brain With BRAF Aberration
  • +2 more
  • Dabrafenib
  • +2 more
  • Phoenix, Arizona
  • +12 more
Apr 7, 2022

metAsTatI? melanOma Treated With dabrafeNib and trAmetinib in

Recruiting
  • Melanoma Stage III
  • +2 more
  • Barnaul, Alatai, Russian Federation
  • +14 more
May 29, 2022

Differentiated Thyroid Cancer Trial in Worldwide (Dabrafenib, Trametinib, Trametinib )

Recruiting
  • Differentiated Thyroid Cancer
  • Dabrafenib
  • +3 more
  • Caba, Buenos Aires, Argentina
  • +41 more
Nov 25, 2022

Melanoma Trial in Italy (dabrafenib, Trametinib)

Recruiting
  • Melanoma
  • Meldola, Forlì-Cesena, Italy
  • +15 more
Mar 18, 2022

Advanced Cancer, Solid Tumor Trial in Helsinki, Kuopio, Tampere (Alectinib, Cobimetinib, Vismodegib)

Recruiting
  • Advanced Cancer
  • Solid Tumor
  • Helsinki, Uusimaa, Finland
  • +2 more
Jun 8, 2022

Cancer Trial in Melbourne (Trametinib, Cobimetinib, Binimetinib)

Recruiting
  • Cancer
  • Melbourne, Victoria, Australia
    Peter MacCallum Cancer Centre
Nov 4, 2022